Insider Transactions in Q2 2023 at Cross Country Healthcare Inc (CCRN)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 14
2023
|
Marc S. Krug Group President, Delivery |
SELL
Payment of exercise price or tax liability
|
Direct |
1,138
-2.45%
|
$30,726
$27.9 P/Share
|
Jun 01
2023
|
Kevin Cronin Clark Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,664
-0.43%
|
$66,600
$25.81 P/Share
|
Jun 01
2023
|
Kevin Cronin Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,812
+0.93%
|
-
|
Jun 01
2023
|
Venkat Bhamidipati Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,812
+43.13%
|
-
|
Jun 01
2023
|
Gale S Fitzgerald Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,812
+6.35%
|
-
|
Jun 01
2023
|
Mark C Perlberg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,584
-1.84%
|
$39,600
$25.81 P/Share
|
Jun 01
2023
|
Mark C Perlberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,812
+6.32%
|
-
|
Jun 01
2023
|
W Larry Cash Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,812
+3.07%
|
-
|
Jun 01
2023
|
Dwayne Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,812
+42.92%
|
-
|
Jun 01
2023
|
Janice Elizabeth Nevin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,664
-9.35%
|
$66,600
$25.81 P/Share
|
Jun 01
2023
|
Janice Elizabeth Nevin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,812
+16.94%
|
-
|
May 10
2023
|
Phillip Lyn Noe Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-6.34%
|
$22,944
$24.29 P/Share
|